Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach (PCa-MAP)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Siemens AG
Mount Vernon Hospital
Multi-Imagem and CDPI, Rio de Janeiro, Brasil
Norwegian University of Science and Technology
University of California, Los Angeles
University Hospital, Ghent
Johns Hopkins University
Medical University of Vienna
University Health Network, Toronto
Heidelberg University
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT01138527
First received: June 4, 2010
Last updated: November 9, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)